Protection by catatoxic steroids against cycloheximide intoxication.
D045930:Anabolic Agents / Q000627:therapeutic use; D000818:Animals; D003513:Cycloheximide / Q000506:poisoning*; D003900:Desoxycorticosterone / Q000627:therapeutic use; D004958:Estradiol / Q000627:therapeutic use; D005032:Ethylestrenol / Q000627:therapeutic use; D005260:Female; D009654:Norsteroids / Q000627:therapeutic use; D010074:Oxandrolone / Q000627:therapeutic use; D011041:Poisoning / Q000517:prevention & control; D011239:Prednisolone / Q000627:therapeutic use; D011276:Pregnanediol / Q000627:therapeutic use; D011277:Pregnanediones / Q000627:therapeutic use; D011374:Progesterone / Q000627:therapeutic use; D051381:Rats; D013148:Spironolactone / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use*; D013974:Thyroxine / Q000627:therapeutic use; D014221:Triamcinolone / Q000627:therapeutic use
D045930:Anabolic Agents; D009654:Norsteroids; D011277:Pregnanediones; D013256:Steroids; D014221:Triamcinolone; D013148:Spironolactone; D003900:Desoxycorticosterone; D011374:Progesterone; D004958:Estradiol; D010074:Oxandrolone; D003513:Cycloheximide; D011239:Prednisolone; D005032:Ethylestrenol; D011276:Pregnanediol; D013974:Thyroxine